EUVIMEDEUVIMED entdecken
Scoping ReviewStudienprotokollOpen Access

Barriers and Facilitators in Diagnostic Pathways That Align Universal Tumor Screening and Mainstream Genetic Testing for Lynch Syndrome in Colorectal Cancer: Protocol for a Scoping Review With a Narrative Synthesis

Linda Battistuzzi iD, Eva Blondeaux iD, Alberto Puccini iD, Luca Boni iD, Federica Grillo iD, Lucia Trevisan iD, Liliana Varesco iD, Maria Stefania Sciallero iD

JMIR Research Protocols · 2025

DOI: 10.2196/70831 ↗

Kurz gefasst

Scoping Review in der Zeitschrift JMIR Research Protocols, 2025. Verfasst von Linda Battistuzzi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Medical Oncology Unit 2, IRCCS Ospedale Policlinico San Martino, Genova, Italy. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Hereditary Nonpolyposis, Genetic Testing, Early Detection of Cancer, Colorectal Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Approximately 3% of colorectal cancers (CRCs) are due to Lynch syndrome (LS), a hereditary cancer syndrome caused by pathogenic variants (PVs) in the mismatch repair (MMR) genes. Patients with CRC and LS have elevated lifetime risks for a range of cancers and require personalized treatment and targeted surveillance. Relatives of people affected by LS who share the same PV also have elevated cancer risks and can benefit from preventive measures and/or risk-reducing surgeries. Despite this, LS remains vastly underdiagnosed. Universal tumor screening (UTS) for deficient MMR is recommended in diagnosing LS in patients with CRC. This process, when combined with genetic testing (GT) offered within routine cancer care (termed “mainstream GT”), aims to identify individuals at risk efficiently, but integrating UTS and mainstream GT for LS in CRC is a complex endeavor.

Objective

The aim of the proposed scoping review will be to comprehensively explore the literature on diagnostic pathways comprising UTS and mainstream GT for LS among patients with CRC and barriers and facilitators in their implementation.

Methods

The scoping review will follow Arksey and O’Malley’s expanded framework. Results will be reported following the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews) guidelines and summarized quantitatively. A narrative synthesis will also be performed using the Theoretical Domains Framework.

Results

The results will be presented in a forthcoming scoping review, which we expect to publish in a peer-reviewed journal by early 2026.

Conclusions

Aligning UTS with mainstream GT for LS in CRC may boost early diagnosis and prevention while reducing waiting times and other patient burdens. By addressing barriers to and facilitators in diagnostic pathways, health care systems can improve the identification and management of LS, ultimately leading to better outcomes for patients and their families. The insights gained from this scoping review will inform the development of a mixed methods study about implementing diagnostic pathways for LS in CRC that integrate UTS and mainstream GT in Italy. International Registered Report Identifier (IRRID) PRR1-10.2196/70831

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal Neoplasms, Hereditary NonpolyposisGenetic TestingEarly Detection of CancerColorectal NeoplasmsHumansScoping Reviews as TopicResearch DesignDNA Mismatch RepairMass Screening

Stichwörter der Autor:innen

Lynch syndromeScoping reviewbarrierscolorectal cancerdiagnostic pathwayfacilitatorsgenetic testingimplementationmainstreamingprotocoltheoretical domains framework

Autor:innen und Institutionen

  • Medical Oncology Unit 2, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
  • Clinical Epidemiology Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
  • Department of Biomedical Sciences, Humanitas University, Milan, Italy.
  • Medical Oncology and Hematology Unit, IRCCS Humanitas Research Hospital, Humanitas Cancer Center, Milan, Italy.
  • Anatomic Pathology Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
  • Department of Surgical and Integrated Diagnostic Sciences, University of Genova, Genova, Italy.

ORCID-Profile: Linda Battistuzzi, Eva Blondeaux, Alberto Puccini, Luca Boni, Federica Grillo, Lucia Trevisan, Liliana Varesco, Maria Stefania Sciallero

Zitieren

APA

Battistuzzi, L., Blondeaux, E., Puccini, A., Boni, L., Grillo, F., Trevisan, L., Varesco, L., & Sciallero, M. S. (2025). Barriers and Facilitators in Diagnostic Pathways That Align Universal Tumor Screening and Mainstream Genetic Testing for Lynch Syndrome in Colorectal Cancer: Protocol for a Scoping Review With a Narrative Synthesis. JMIR Research Protocols. https://doi.org/10.2196/70831

Vancouver

Battistuzzi L, Blondeaux E, Puccini A, Boni L, Grillo F, Trevisan L, et al. Barriers and Facilitators in Diagnostic Pathways That Align Universal Tumor Screening and Mainstream Genetic Testing for Lynch Syndrome in Colorectal Cancer: Protocol for a Scoping Review With a Narrative Synthesis. JMIR Research Protocols. 2025. doi:10.2196/70831

BibTeX
@article{Battistuzzi2025,
  author = {Battistuzzi, Linda and Blondeaux, Eva and Puccini, Alberto and Boni, Luca and Grillo, Federica and Trevisan, Lucia and Varesco, Liliana and Sciallero, Maria Stefania},
  title = {Barriers and Facilitators in Diagnostic Pathways That Align Universal Tumor Screening and Mainstream Genetic Testing for Lynch Syndrome in Colorectal Cancer: Protocol for a Scoping Review With a Narrative Synthesis},
  journal = {JMIR Research Protocols},
  year = {2025},
  doi = {10.2196/70831}
}
Kostenlos starten →